MOESM8 of Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells
2019-10-11T05:37:30Z (GMT) by
Additional file 8. Figure S8. CCK8 assay showing passively activating mTOR by MHY1485 reversed the inhibiting effect of docetaxel on viability of PAD2 knockdown (a) or miR-125b-5p overexpression (b) MCF7/TamR cells. shCon: shRNA control MCF7/TamR cells; shPAD2: PAD2 knockdown cells; EV con: Empty vector pQXCIP overexpression MCF7/TamR cells; miR-125b-5p: miR-125b-5p overexpression cells; Doc: docetaxel; PBS was used as a control. (*P < 0.05).